logo

EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link:  https://ebookbell.com/faq 


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Neuroinflammation Mechanisms And Management 2nd Edition Paul L Wood

  • SKU: BELL-932892
Neuroinflammation Mechanisms And Management 2nd Edition Paul L Wood
$ 31.00 $ 45.00 (-31%)

4.8

54 reviews

Neuroinflammation Mechanisms And Management 2nd Edition Paul L Wood instant download after payment.

Publisher: Humana Press
File Extension: PDF
File size: 8.26 MB
Pages: 434
Author: Paul L. Wood
ISBN: 9781588290021, 1588290026
Language: English
Year: 2002
Edition: 2

Product desciption

Neuroinflammation Mechanisms And Management 2nd Edition Paul L Wood by Paul L. Wood 9781588290021, 1588290026 instant download after payment.

In an unprecedented integration of cutting-edge ideas in immunology with clinical neuropathological findings, Neuroinflammation: Mechanisms and Management reviews and synthesizes our knowledge of the inflammatory mediators and cells involved in neurodegenerative diseases. Beginning with a detailed review of the role of biochemical mediators in neuronal loss and the mechanisms of cell death, the distinguished contributors critically examine research on the design of specific pharmacological agents to inhibit defined points in the neuroinflammatory cascade. They also address the molecular, cellular, and therapeutic actions of first generation agents, as well as their potential clinical relevance to AIDS dementia, Alzheimer's disease, amyotropic lateral sclerosis (ALS), Down's syndrome, Huntington's disease, multiple sclerosis, Parkinson's disease, and stroke.

Related Products